Free Trial

HSBC Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price

Lam Research logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • HSBC raised its price target on Lam Research to $247 (from $221) but kept a "hold" rating—its target implies about a 7.8% downside—while overall analyst sentiment is bullish (26 Buys vs. 8 Holds) with a consensus "Moderate Buy" and an average target of $284.49.
  • Q3 results beat expectations: EPS $1.47 vs. $1.36 expected and revenue $5.84B vs. $5.70B, with revenue up 23.8% YoY and management setting Q4 FY2026 EPS guidance of $1.50–$1.80, as analysts point to AI-driven chip spending fueling a multi-year WFE upcycle.
  • Notable insider selling occurred recently (director and CFO sales of 35,000 and 50,057 shares), with insiders selling 130,886 shares worth roughly $29.7M in the last quarter, even as institutional ownership remains high (~84.6%).
  • Five stocks to consider instead of Lam Research.

Lam Research (NASDAQ:LRCX - Get Free Report) had its target price boosted by HSBC from $221.00 to $247.00 in a report released on Friday,MarketScreener reports. The brokerage presently has a "hold" rating on the semiconductor company's stock. HSBC's target price points to a potential downside of 7.76% from the stock's previous close.

Other equities analysts have also issued research reports about the company. Bank of America raised their price target on Lam Research from $285.00 to $330.00 and gave the company a "buy" rating in a research note on Thursday. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $290.00 price objective on shares of Lam Research in a research note on Thursday. Berenberg Bank raised their target price on shares of Lam Research from $265.00 to $335.00 and gave the company a "buy" rating in a research report on Thursday. Summit Insights upgraded shares of Lam Research from a "hold" rating to a "buy" rating in a report on Thursday, January 29th. Finally, Needham & Company LLC reissued a "buy" rating and set a $300.00 price objective on shares of Lam Research in a report on Thursday. Twenty-six analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $284.49.

View Our Latest Research Report on Lam Research

Lam Research Price Performance

Shares of LRCX stock opened at $267.78 on Friday. The company's 50-day simple moving average is $234.99 and its two-hundred day simple moving average is $197.84. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.61. Lam Research has a one year low of $68.53 and a one year high of $275.84. The company has a market capitalization of $334.40 billion, a P/E ratio of 50.52, a P/E/G ratio of 2.69 and a beta of 1.78.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.11. The firm had revenue of $5.84 billion during the quarter, compared to analyst estimates of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.Lam Research's quarterly revenue was up 23.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, equities analysts anticipate that Lam Research will post 5.43 EPS for the current year.

Insider Buying and Selling at Lam Research

In other news, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares in the company, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Douglas R. Bettinger sold 50,057 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the sale, the chief financial officer directly owned 1,081,705 shares in the company, valued at $242,334,371.15. This trade represents a 4.42% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 130,886 shares of company stock worth $29,658,802. 0.31% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Lam Research

A number of large investors have recently bought and sold shares of the company. PMV Capital Advisers LLC acquired a new stake in shares of Lam Research in the fourth quarter worth $25,000. Stance Capital LLC purchased a new stake in shares of Lam Research in the third quarter worth about $26,000. Bayban purchased a new position in Lam Research during the fourth quarter valued at approximately $26,000. Vermillion Wealth Management Inc. acquired a new position in Lam Research in the first quarter valued at approximately $26,000. Finally, Triumph Capital Management acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $27,000. Hedge funds and other institutional investors own 84.61% of the company's stock.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Q3 results beat expectations (EPS $1.47, revenue $5.84B) and management gave strong FY guidance tied to AI demand — investors view this as confirmation of a multi-year WFE upcycle. Earnings & press coverage
  • Positive Sentiment: Major analysts have lifted price targets across the board (examples: TD Cowen $340, Susquehanna $385, JPMorgan $315, BofA $330), signaling upgraded revenue and margin forecasts driven by AI memory and logic chip spending. Analyst target upgrades
  • Positive Sentiment: Several bank research notes reiterated buy/outperform ratings and sizable upside, reinforcing momentum and prompting institutional buyers to add exposure. Deutsche Bank price target raise
  • Neutral Sentiment: Broad market action (Dow slip while Nasdaq gains) and strong moves in other chip names (Intel, AMD, Arm) contributed to sector flow into semiconductor-equipment names including LRCX. Market breadth coverage
  • Neutral Sentiment: Not all firms moved to buy: a few kept neutral/equal-weight stances (e.g., Morgan Stanley, BNP Paribas), showing some analysts want to see more cycles of delivery before upgrading conviction. Morgan Stanley note
  • Negative Sentiment: Valuation concerns: commentary and analysis warn the stock reflects a lot of AI upside already — some investors may view multiple and momentum as stretched, which could amplify pullbacks on any growth-slow surprises. Valuation caution analysis

About Lam Research

(Get Free Report)

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Analyst Recommendations for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines